BRPI0913783A2 - método de tratamento, profilático ou terapêutico de exposição à radiação ou envenenamento por radiação, método de aceleração de restauração de medula óssea, método de aceleração da mielorrestauração, método de estimulação da liberação de citocinas, método de indução de trombocitose e micropartícula-mdp ou uma composição - Google Patents

método de tratamento, profilático ou terapêutico de exposição à radiação ou envenenamento por radiação, método de aceleração de restauração de medula óssea, método de aceleração da mielorrestauração, método de estimulação da liberação de citocinas, método de indução de trombocitose e micropartícula-mdp ou uma composição

Info

Publication number
BRPI0913783A2
BRPI0913783A2 BRPI0913783A BRPI0913783A BRPI0913783A2 BR PI0913783 A2 BRPI0913783 A2 BR PI0913783A2 BR PI0913783 A BRPI0913783 A BR PI0913783A BR PI0913783 A BRPI0913783 A BR PI0913783A BR PI0913783 A2 BRPI0913783 A2 BR PI0913783A2
Authority
BR
Brazil
Prior art keywords
acceleration
radiation
myelorestation
thrombocytosis
mdp
Prior art date
Application number
BRPI0913783A
Other languages
English (en)
Portuguese (pt)
Inventor
Frank B Gelder
Gillian Alison Webster
Original Assignee
Innate Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Therapeutics Ltd filed Critical Innate Therapeutics Ltd
Publication of BRPI0913783A2 publication Critical patent/BRPI0913783A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1094—Shielding, protecting against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BRPI0913783A 2008-09-30 2009-09-30 método de tratamento, profilático ou terapêutico de exposição à radiação ou envenenamento por radiação, método de aceleração de restauração de medula óssea, método de aceleração da mielorrestauração, método de estimulação da liberação de citocinas, método de indução de trombocitose e micropartícula-mdp ou uma composição BRPI0913783A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ571665A NZ571665A (en) 2008-09-30 2008-09-30 Compositions and methods for treatment of radiation exposure utilising cross-linked muramyl dipeptide microparticles
PCT/NZ2009/000207 WO2010039048A1 (en) 2008-09-30 2009-09-30 Compositions and methods for treatment of radiation exposure

Publications (1)

Publication Number Publication Date
BRPI0913783A2 true BRPI0913783A2 (pt) 2016-11-01

Family

ID=42073685

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913783A BRPI0913783A2 (pt) 2008-09-30 2009-09-30 método de tratamento, profilático ou terapêutico de exposição à radiação ou envenenamento por radiação, método de aceleração de restauração de medula óssea, método de aceleração da mielorrestauração, método de estimulação da liberação de citocinas, método de indução de trombocitose e micropartícula-mdp ou uma composição

Country Status (10)

Country Link
US (1) US10232010B2 (enExample)
EP (1) EP2349311B1 (enExample)
JP (2) JP6053283B2 (enExample)
CN (1) CN102170898A (enExample)
AU (1) AU2009300442B2 (enExample)
BR (1) BRPI0913783A2 (enExample)
CA (1) CA2738622C (enExample)
ES (1) ES2435438T3 (enExample)
NZ (1) NZ571665A (enExample)
WO (1) WO2010039048A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2926507A1 (en) * 2015-10-06 2017-04-06 Innate Immunotherapeutics Limited Compositions and methods for protection and/or repair of the nervous system
WO2017059486A1 (en) * 2015-10-06 2017-04-13 Innate Immunotherapeutics Limited Compositions and methods for the treatment of epilepsy
WO2017070731A1 (en) * 2015-10-28 2017-05-04 Innate Immunotherapeutics Limited Compositions and methods for the treatment of alzheimer's disease
CN108273038B (zh) * 2018-03-16 2019-03-19 中国人民解放军军事科学院军事医学研究院 防治肠型放射病的药物组合物
CN111060697A (zh) * 2019-02-24 2020-04-24 中国疾病预防控制中心辐射防护与核安全医学所 一种利用hmgb1的小肠放射性损伤标记方法
WO2022150763A1 (en) * 2021-01-11 2022-07-14 The George Washington University Nanoparticle-mediated immune cell manufacture and uses thereof
US12245355B2 (en) 2021-02-19 2025-03-04 Mevion Medical Systems, Inc. Gantry for a particle therapy system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
AU686660B2 (en) * 1993-08-11 1998-02-12 Jenner Technologies Prostatic cancer vaccine
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
AU732809B2 (en) * 1996-10-10 2001-05-03 Innate Immunotherapeutics Limited Compositions and methods for treating viral infections
AU752255B2 (en) * 1998-10-23 2002-09-12 Polyheal Ltd. Compositions of microspheres for wound healing
EP2271352A4 (en) * 2008-04-01 2014-01-15 Innate Therapeutics Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF NEOPLASTIC DISEASES

Also Published As

Publication number Publication date
EP2349311A4 (en) 2012-07-04
ES2435438T3 (es) 2013-12-19
EP2349311A1 (en) 2011-08-03
JP2012504161A (ja) 2012-02-16
JP2016026157A (ja) 2016-02-12
JP6053283B2 (ja) 2016-12-27
US20110236346A1 (en) 2011-09-29
AU2009300442B2 (en) 2014-03-13
CA2738622C (en) 2016-10-18
CA2738622A1 (en) 2010-04-08
NZ571665A (en) 2011-01-28
EP2349311B1 (en) 2013-08-21
CN102170898A (zh) 2011-08-31
AU2009300442A1 (en) 2010-04-08
US10232010B2 (en) 2019-03-19
WO2010039048A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
DE602007011908D1 (de) Verwendung von gpr119-rezeptoragonisten zur vermehrung der knochenmasse und zur behandlung von osteoporose sowie kombinationstherapie dafür
BRPI0914387A2 (pt) sistema de tratamento abdominal, método de tratamento de uma cavidade abdominal aberta, e, método de fabricação de um sistema para tratamento de uma cavidade abdominal de um paciente
PL2087913T3 (pl) System i sposób sterylizacji wszczepialnego urządzenia medycznego
EP2303160A4 (en) BONE FRACTURE TREATMENT DEVICES AND METHODS OF USE
EP2222240A4 (en) DEVICE AND METHOD FOR ATTACHING AN ORTHOPEDIC FRACTURE
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
BRPI0822920A2 (pt) Implante médico e método de implantação
EP2051662A4 (en) MEDICAL DEVICE FOR REPAIRING TISSUE AND METHOD FOR IMPLANTING AND FIXING THE SAME
BRPI0909180A2 (pt) composição farmacêutica, e, método de tratamento de uma doença autoimune
EP2240103A4 (en) SYSTEM AND METHOD FOR FIXING BONE FRACTURES
BRPI0909048A2 (pt) composição farmacêutica, e, método de tratamento de uma doença autoimune
EP2007296A4 (en) METHOD AND DEVICE FOR LEG BENT FIXING
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
IL207713A0 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
BRPI0916235A2 (pt) composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
IL194820A0 (en) Devices and methods for treatment of tissue
BRPI0921889A2 (pt) dispositivos médicos assimétricos para tratamento de um local-alvo e método associado
BRPI0909179A2 (pt) Composição farmacêutica, e, método de tratamento de uma doença autoimune.
EP2505176A4 (en) DEVICE FOR INCREASING HUMAN HEALTH CAPACITY AND METHOD FOR OPERATING THE DEVICE TO INCREASE HUMAN HEALTH ABILITY
DK3064579T3 (da) Farmaceutiske sammensætninger og medicinske anvendelsesformer af konstruerede humane arginaser
BRPI1008171A2 (pt) dispositivo para tratamento terapêutico e/ou exercício dos membros inferiores de uma pessoa
BR112013009294A2 (pt) componente dental, fixação dental, conjunto de implante dental e sistema de implante dental
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
FI20060532A0 (fi) Menetelmä ja laitteisto lääketieteelliseen röntgenkuvantamiseen
ZA201103322B (en) Bone implant matrix and method of preparing the same

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements